Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort
Objective: To determine the longitudinal differences in cognitive tests in participants with Parkinson’s disease (PD), and the neuropsychological tests most sensitive to change over and…Plasma Soluble ST2 (sST2) levels are Higher in Neurodegeneration and Associate with PD Cognition
Objective: As plasma IL-33 levels are too low to accurately quantify, we measured plasma sST2 as a surrogate marker for IL-33 in samples from healthy…Cognitive impairment in Parkinson’s Disease: A cross-sectional association study
Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors…Predicting DRS-2 Total scores from the MoCA
Objective: Evaluate whether the Montreal Cognitive Assessment (MoCA) score is predictive of Dementia Rating Scale - 2 (DRS-2) score in the clinical evaluation of deep brain stimulation (DBS) candidates, in an…Dorsolateral striatal neuronal activity in a rat model of Parkinson`s disease with levodopa-induced dyskinesias
Objective: This study aimed to investigate the firing properties of fast spiking interneurons (FSIs) and medium spiny neurons (MSNs) of the dorsomedial striatum (DLStr) and…Widespread distribution and abundant accumulation of alpha-synuclein oligomers in multiple system atrophy brain
Objective: To examine the distribution of alpha-synuclein (αSyn) oligomers as an early pathological change in multiple system atrophy (MSA) brains. Background: Although severe neuronal loss…Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson’s disease patients
Objective: To establish a registry of PD patients in Thailand treated with subcutaneous apomorphine (APO) injection or infusion to allow prospective data collection from the…Antipsychotics Use in Parkinson’s Disease and Mortality Risks
Objective: To describe the use of antipsychotics in patients with Parkinson’s disease (PD) and study its associated mortality risks. Background: The US Food and Drug…Prevalence of Parkinsonian Syndrom in the World
Objective: To study epidemiological condition of Parkinson disease in the world. Background: Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system…Midbrain Atrophy in Patients with Preclinical Progressive Supranuclear Palsy
Objective: In the present study, midbrain atrophy and the pons-to-midbrain area ratio (P/M ratio) were investigated as diagnostic markers for preclinical progressive supranuclear palsy (Pre-PSP).…
- « Previous Page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- …
- 217
- Next Page »